New shot aims to stop bleeding in rare blood disorder
Disease control
Recruiting now
This study tests a new medicine called VGA039, given as a shot under the skin, to prevent bleeding episodes in people with von Willebrand disease (VWD). About 60 teens and adults aged 12 to 75 with frequent bleeds will receive the drug and be monitored for safety and how well it …
Phase: PHASE3 • Sponsor: Vega Therapeutics, Inc • Aim: Disease control
Last updated May 13, 2026 16:03 UTC